查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球肺功能测试市场
市场调查报告书
商品编码
1296934

2023-2030年全球肺功能测试市场

Global Pulmonary Function Testing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 105 Pages | 商品交期: 2-3个工作天内

价格

在预测期内，全球肺功能测试市场预计将以8.3%的年复合增长率增长。全球肺功能检测系统的市场需求受到肺部相关疾病发病率上升、肺功能检测系统的技术进步和职业性肺部疾病的推动。例如，2023年4月，阿桑医疗中心（AMC）开发了一种人工智能肺部测试设备，可以根据计算机断层扫描（CT）测试结果预测肺部功能，准确率达到90%以上。这种算法能够根据CT扫描结果识别肺功能下降的患者。此外，该人工智能被发现可以根据测量强制生命力（FVC），和一秒内强制呼气量（FEV1）来预测高风险指标，准确率约为85%。

此外，公共和私人组织的资金增加将进一步推动市场增长。2023年4月，诺亚医疗筹集了1.5亿美元，以帮助建立其银河系统背后的商业引擎，旨在使用一次性探针进行导航式肺部支气管镜检查。银河系统等下一代机器人平台正在填补程序上的空白，以提供卓越的临床价值，更好地满足客户的需求。该系统还配备了诺亚所称的Tool-in-Lesion Tomo+技术，或TiLT+，它为外科医生提供实时、图像引导的更新，以帮助确认活检工具何时完全进入其目标组织。

目录

第一章：报告摘要

  • 研究方法和工具
  • 市场细分
    • 按领域划分
    • 按地理区域分类

第二章：市场概述和洞察力

  • 报告的范围
  • 分析师的洞察力和当前的市场趋势
    • 主要发现
    • 建议
    • 总结
  • 规则和条例

第三章：竞争格局

  • 主要公司分析
    • Koninklijke Philips N.V.
    • ResMed Inc.
    • Thermo Fisher Scientific Inc.
  • 关键战略分析

第四章：市场细分

  • 按设备类型分類的全球肺功能测试市场
    • 手持式
    • 台式
  • 按产品类型分類的全球肺功能测试市场
    • 肺量计
    • 肺容积测试
    • 动脉血气测试
    • 脉搏血氧仪
    • 其他（最大自愿通气）。
  • 全球肺功能测试市场的应用
    • 呼吸道感染
    • 哮喘
    • 石棉病
    • 肿瘤
    • 肉毒杆菌病
    • 其他（胸部手术）。
  • 按终端用户分類的全球肺功能测试市场
    • 医院
    • 临床实验室
    • 诊断学实验室

第五章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 亚太其他地区
  • 世界其他地区

第六章：公司简介

  • Carestream Health.
  • Carestream Health.
  • Chest M.I., Inc.
  • Cosmed Srl
  • Ganshorn Medizin Electronic GmbH
  • Koko, Llc
  • Medical Electronic Corp.
  • Medical Equipment Europe GmbH
  • Mgc Diagnostics Corp.
  • Minato Medical Science Co.
  • Morgan Scientific Inc.
  • ndd Medical Technologies, Inc.
  • Omron Healthcare, Inc.
  • PulmOne USA Inc.
  • Vyaire Medical, Inc.
Product Code: OMR2027409

Title: Global Pulmonary Function Testing Market Size, Share & Trends Analysis Report by Device Type (Handheld, and Tabletop), by Product Type (Spirometry, Lung Volume Testing, Arterial Blood Gas Testing, Pulse Oximetry, and Others (Maximal Voluntary Ventilation)), by Application (Respiratory Infections, Asthma, Asbestosis, Tumors, Sarcoidosis, and Others (chest surgery), and by End User (Hospitals, Clinical Laboratories, and Diagnostics Laboratories) Forecast Period (2023-2030).

The global pulmonary function testing market is anticipated to grow at a CAGR of 8.3% during the forecast period. Global pulmonary function testing systems market demand is fueled by the rising incidence of lung-related disorders, technological advancements in pulmonary function testing systems and occupational lung diseases. For instance, in April 2023, Asan Medical Center (AMC) developed an artificial intelligence lung testing device that predicts lung function based on computed tomography (CT) test results with an accurate rate of 90% or higher. This algorithm is capable of identifying patients with decreased lung function based on CT scans. Moreover, the AI was found to predict the high-risk indicator based on both measurements forced vital capacity (FVC), and forced expiratory volume in one second (FEV1) with approximately 85% accuracy.

In addition, increasing funding by public and private organizations will further propel the market growth. In April 2023, Noah Medical raised $150 million to help build a commercial engine behind its Galaxy system, designed to perform navigated lung bronchoscopies using disposable probes. Next-generation robotics platforms such as Galaxy System are filling procedural gaps to provide superior clinical values to better serve customers' needs. The system is also equipped with what Noah has dubbed Tool-in-Lesion Tomo+ technology, or TiLT+, which provides surgeons with real-time, image-guided updates to help confirm when the biopsy tool is fully within its target tissue.

Segmental Outlook

The global pulmonary function testing market is segmented based on its device type, product type, application, and end user. Based on device type, the market is bifurcated into handheld, and tabletop. Based on product type, the market is categorized into spirometry, lung volume testing, arterial blood gas testing, pulse oximetry, and others. Based on application, the market is divided into respiratory infections, asthma, asbestosis, tumors, sarcoidosis, and others. Based on end user, the market is segmented into hospitals, clinical laboratories, and diagnostics laboratories. Based on product type, the spirometry segment holds a significant market share. Increasing the use of spirometry for detecting lung infection is driving the segment growth. Spirometry tells whether the patient has a breathing problem caused by an obstruction of air that's left in his or her lungs or a restriction of air entering the lung.

The Sarcoidosis Segment Holds a Significant Share in the Global Pulmonary Function Testing Market

Based on application, the sarcoidosis segment is projected to witness significant growth during the forecast period. An increase in awareness regarding sarcoidosis diseases, along with extensive funding provided by regulatory bodies positively influences the market growth. For instance, in October 2022, Xentria has raised $25 million in funding to further the development of XTMAB-16, its experimental antibody therapy for sarcoidosis. With this funding, the company advance the Xentria pipeline and execute against the goal of developing critical therapeutics for patients in need. Furthermore, according to the Foundation for Sarcoidosis Research, in 2021 nearly 175,000 people in the US have sarcoidosis, with an estimated 1.2 million individuals living with the disease globally.

Regional Outlooks

The global pulmonary function testing market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Europe region is projected to hold a significant share in the pulmonary function testing market. A considerable increase in the incidence of chronic obstructive pulmonary diseases and asthma cases, along with numerous campaigns organized by regulatory bodies to create awareness among the people, drive the market growth.

Global Pulmonary Function Testing Market Growth, by Region 2023-2030

Source: OMR Analysis

The North America Region Holds a Prominent Market Share in the Global Pulmonary Function Testing Market

Based on region, North America is projected to have the highest CAGR over the forecast period. Rising technological advancements in diagnostics, well-developed pulmonary healthcare infrastructure, increasing prevalence of chronic respiratory diseases, are the primary factor that boost the market growth. For instance, in September 2022, Optellum, AI Lung Cancer diagnosis innovator, secures $14million Series A funding to accelerate expansion. This first-of-a-kind platform help physicians identify and track at-risk patients, and optimally diagnose the signs of lung cancer early, so treatment can be started sooner for patients with tumors, and invasive procedures such as biopsies on benign lesions can be minimized.

Market Players Outlook

The major companies serving the global pulmonary function testing market include Ganshorn Medizin Electronic GmbH, KoKo, LLC, Koninklijke Philips N.V., Medical Electronic Corp., NDD Medical Technologies, and others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2020, NDD Medical Technologies (ndd), introduced single patient-use, inline filters for its lung function testing devices in response to COVID-19. Ensuring added safety, the filters complement NDD's revolutionary, highly portable EasyOne spirometry range, including EasyOne Air, Pro, and Pro LAB. Ndd's popular spirometers are of the most sensitive devices, delivering reliable, real-time lung function results and enabling specialists diagnoses of chronic lung diseases, even at the point of care.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global pulmonary function testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Koninklijke Philips N.V.
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. ResMed Inc.
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. Thermo Fisher Scientific Inc.
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Pulmonary Function Testing Market by Device Type
    • 4.1.1. Handheld
    • 4.1.2. Tabletop
  • 4.2. Global Pulmonary Function Testing Market by Product Type
    • 4.2.1. Spirometry
    • 4.2.2. Lung Volume Testing
    • 4.2.3. Arterial Blood Gas Testing
    • 4.2.4. Pulse Oximetey
    • 4.2.5. Others (Maximal Voluntary Ventilation)
  • 4.3. Global Pulmonary Function Testing Market by Application
    • 4.3.1. Respiratory Infections
    • 4.3.2. Asthma
    • 4.3.3. Asbestosis
    • 4.3.4. Tumors
    • 4.3.5. Sarcoidosis
    • 4.3.6. Others (Chest Surgery)
  • 4.4. Global Pulmonary Function Testing Market by End User
    • 4.4.1. Hospitals
    • 4.4.2. Clinical Laboratories
    • 4.4.3. Diagnostics Laboratories

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Carestream Health.
  • 6.2. Carestream Health.
  • 6.3. Chest M.I., Inc.
  • 6.4. Cosmed Srl
  • 6.5. Ganshorn Medizin Electronic GmbH
  • 6.6. Koko, Llc
  • 6.7. Medical Electronic Corp.
  • 6.8. Medical Equipment Europe GmbH
  • 6.9. Mgc Diagnostics Corp.
  • 6.10. Minato Medical Science Co.
  • 6.11. Morgan Scientific Inc.
  • 6.12. ndd Medical Technologies, Inc.
  • 6.13. Omron Healthcare, Inc.
  • 6.14. PulmOne USA Inc.
  • 6.15. Vyaire Medical, Inc.

LIST OF TABLES

  • 1. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL HANDHELD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL TABLETOP PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 5. GLOBAL PULMONARY SPIROMETRY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL PULMONARY LUNG VOLUME FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL PULMONARY ARTERIAL BLOOD GAS FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL PULSE OXIMETRY PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL OTHERS PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 11. GLOBAL PULMONARY FUNCTION TESTING FOR RESPIRATORY INFECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL PULMONARY FUNCTION TESTING FOR ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL PULMONARY FUNCTION TESTING FOR ASBESTOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL PULMONARY FUNCTION TESTING FOR TUMORS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL PULMONARY FUNCTION TESTING FOR SARCOIDOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL PULMONARY FUNCTION TESTING FOR OTHERS (CHEST SURGERY) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 18. GLOBAL PULMONARY FUNCTION TESTING IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. GLOBAL PULMONARY FUNCTION TESTING IN CLINICAL LABORATRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 20. GLOBAL PULMONARY FUNCTION TESTING IN DIAGNOSTICS LABORATRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 21. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 25. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 27. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 29. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 30. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 31. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 32. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 33. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 34. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 35. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 36. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 39. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 40. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 41. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL HANDHELD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL TABLETOP PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 5. GLOBAL PULMONARY SPIROMETRY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL PULMONARY LUNG VOLUME FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL PULMONARY ARTERIAL BLOOD GAS FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL PULSE OXIMETRY PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL OTHERS PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
  • 11. GLOBAL PULMONARY FUNCTION TESTING FOR RESPIRATORY INFECTIONS MARKET RESEARCH AND ANALYSIS BY REGION,2022 VS 2030 (%)
  • 12. GLOBAL PULMONARY FUNCTION TESTING FOR ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL PULMONARY FUNCTION TESTING FOR ASBESTOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL PULMONARY FUNCTION TESTING FOR TUMORS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL PULMONARY FUNCTION TESTING FOR SARCOIDOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL PULMONARY FUNCTION TESTING FOR OTHERS (CHEST SURGERY) MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022 VS 2030 (%)
  • 18. GLOBAL PULMONARY FUNCTION TESTING IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 19. GLOBAL PULMONARY FUNCTION TESTING IN CLINICAL LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 20. GLOBAL PULMONARY FUNCTION TESTING IN DIAGNOSTICS LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 21. US PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CANADA PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. UK PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. FRANCE PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. GERMANY PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. ITALY PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SPAIN PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. ROE PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. INDIA PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. CHINA PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. JAPAN PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)